-
EASL Expert Interview | Overcoming Limitations in Liver Cancer Screening: Application and Prospects of “HelioLiver Dx” in Early Diagnosis of Liver Cancer
Traditional screening methods in the field of liver cancer prevention and treatment face numerous challenges. At the 2024 European Association for the Study of the Liver (EASL) Annual Meeting, the CLiMB trial, led by Professor Richard Van Etten, Director of the UCI Chao Family Comprehensive Cancer Center in the United States, achieved significant results in…
-
Professor Zhijie Wei: Salvage Haplo-HCT Combined with Unrelated Cord Blood Infusion Improves Survival and Reduces aGVHD in Non-Remission AML Patients
The 29th Annual Meeting of the European Hematology Association (EHA) was grandly held in Madrid, Spain, from June 13 to 16, 2024. The EHA conference featured numerous captivating presentations, particularly in the area of non-remission acute myeloid leukemia (NR-AML), which attracted significant attention. A study by Professor Zhijie Wei’s team from Beijing Lu Daopei Hospital,…
-
Professor Jia Wei’s Team: Exceptional Efficacy of Dual-Targeted CD19/20 CAR-T Therapy in Treating Relapsed/Refractory B-Cell Lymphoma Patients
The 29th Annual Meeting of the European Hematology Association (EHA) was grandly held in Madrid, Spain, from June 13 to 16, 2024. As the largest international conference in the field of hematology in Europe, it annually attracts experts and scholars from around the world to share and discuss innovative ideas and the latest scientific and…
-
EHA Expert Interview with Professor Yang Liang: Immune-Based Insights into Secondary Resistance to Anti-CD38 Therapy in Multiple Myeloma
The 29th Annual Meeting of the European Hematology Association (EHA) was held from June 13 to 16, 2024, in Madrid, Spain. As the largest international conference in the field of hematology in Europe, it attracts experts and scholars from around the world to share and discuss innovative ideas and the latest scientific and clinical research…
-
EHA China Voice丨Professor Liang Wang’s Team: Exploring Optimal Treatment for Vitreoretinal Lymphoma
The 29th Annual Meeting of the European Hematology Association (EHA) was grandly held from June 13 to 16, 2024, in Madrid, Spain. As the largest international conference in the field of hematology in Europe, it attracts experts and scholars from around the world every year to share and discuss innovative ideas and the latest scientific…
-
Prof. Yue Lu’s Team Compares ATG-T vs. ATLG in TBI-Based Conditioning for Alternative Donor Allogeneic Hematopoietic Stem Cell Transplantation
The 29th Annual Meeting of the European Hematology Association (EHA) was held from June 13 to 16, 2024, in Madrid, Spain. As the largest international conference in the field of hematology in Europe, it attracts experts and scholars from around the world each year to share and discuss innovative ideas and the latest scientific and…
-
EHA-CSH Joint Symposium: Professor Jianxiang Wang on Sino-European Hematology Exchange and Future Development
The 29th Annual Congress of the European Hematology Association (EHA) took place from June 13 to 16, 2024, in Madrid, Spain. Renowned as the “Olympics” of European hematology, the EHA Congress is celebrated for its cutting-edge scientific discussions and extensive clinical research findings, drawing global attention. Among the numerous highlights of this year’s event was…
-
Preview of APACC 2024丨Dr. Shenglan Tang: Implementation and Policy of HPV Vaccination
The Asia-Pacific AIDS & Co-Infections Conference (APACC) 2024 will be held in Hong Kong as a hybrid conference on 27-29 June 2024. During Parallel Session 5: Women’s Health – HPV, Professor Shenglan Tang from Duke Kunshan University will deliver a presentation titled “Implementation / Policy of HPV Vaccination”.
Connecting Medical Expertise through Media